Literature DB >> 25056943

Testosterone persistently dysregulates hepatic expression of Tlr6 and Tlr8 induced by Plasmodium chabaudi malaria.

Saleh Al-Quraishy1, Mohamed A Dkhil, Abdel-Azeem S Abdel-Baki, Marcos J Araúzo-Bravo, Denis Delic, Frank Wunderlich.   

Abstract

Testosterone (T) is known to induce persistent susceptibility to Plasmodium chabaudi malaria. Pathogens recognizing Toll-like receptors (TLRs), though potentially important against malaria, have not yet been examined for their T-sensitivity. Here, we investigate effects of T and P. chabaudi on mRNA expression and promoter DNA methylation of Tlr1-9 genes in the liver of female C57BL/6 mice. These are treated with T or vehicle for 3 weeks, and then treatment is discontinued for 12 weeks, before challenging with P. chabaudi for 8 days. Our data reveal that T induces a 9.1-fold downregulation of Tlr6 mRNA and 6.3-fold upregulation of Tlr8 mRNA. Blood-stage infections induce significant increases in mRNA expression of Tlr1, 2, 4, 6, 7, and 8 varying between 2.5-fold and 21-fold in control mice. In T-pretreated mice, these Tlr genes are also significantly responsive to infections. However, the malaria-induced upregulations of the relative mRNA expressions of Tlr6 and Tlr8 are 5.6-fold higher and 6.5-fold lower in T-pretreated mice than in control mice. Infections induce a massive DNA down-methylation of the Tlr6 gene promoter in control mice, which is still more pronounced in T-pretreated mice, while significant changes are not detectable for the DNA methylation status of the Tlr8 promoter. Our data support the view that hepatic expression of Tlr6, but not that of Tlr8 is epigenetically controlled, and that the dysregulations of Tlr6 and Tlr8 critically contribute to T-induced persistent susceptibility to P. chabaudi malaria, possibly by dys-balancing responses of TLR6-mediated pathogen recognition and TLR8-mediated generation of anti-malaria "protective" autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25056943     DOI: 10.1007/s00436-014-4026-2

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  68 in total

1.  Effect of testosterone on Leishmania donovani infection of macrophages.

Authors:  H Zhang; J Zhao; P Wang; Z Qiao
Journal:  Parasitol Res       Date:  2001-08       Impact factor: 2.289

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 3.  Sex-associated hormones and immunity to protozoan parasites.

Authors:  C W Roberts; W Walker; J Alexander
Journal:  Clin Microbiol Rev       Date:  2001-07       Impact factor: 26.132

4.  Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination.

Authors:  David Furman; Boris P Hejblum; Noah Simon; Vladimir Jojic; Cornelia L Dekker; Rodolphe Thiébaut; Robert J Tibshirani; Mark M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-23       Impact factor: 11.205

5.  Association of intermediate T cell receptor cells, mainly their NK1.1(-) subset, with protection from malaria.

Authors:  A Weerasinghe; H Sekikawa; H Watanabe; K Mannoor; S R Morshed; R C Halder; T Kawamura; T Kosaka; C Miyaji; H Kawamura; S Seki; T Abo
Journal:  Cell Immunol       Date:  2001-01-10       Impact factor: 4.868

6.  Genes of the mouse H-2 complex control the efficacy of testosterone to suppress immunity against the intestinal nematode Heterakis spumosa.

Authors:  A Harder; A Danneschewski; F Wunderlich
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

7.  Cryptic disposition of antigenic parasite proteins in plasma membranes of erythrocytes infected with Plasmodium chabaudi.

Authors:  F Wunderlich; M Helwig; G Schillinger; V Speth
Journal:  Mol Biochem Parasitol       Date:  1988-07       Impact factor: 1.759

8.  Testosterone impairs efficacy of protective vaccination against P. chabaudi malaria.

Authors:  F Wunderlich; W Maurin; W P Benten; H P Schmitt-Wrede
Journal:  Vaccine       Date:  1993       Impact factor: 3.641

Review 9.  Toll-like receptor -1, -2, and -6 polymorphisms and pulmonary tuberculosis susceptibility: a systematic review and meta-analysis.

Authors:  Yuxiang Zhang; Tingting Jiang; Xiuyun Yang; Yun Xue; Chong Wang; Jiyan Liu; Xing Zhang; Zhongliang Chen; Mengyuan Zhao; Ji-Cheng Li
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

Review 10.  Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases.

Authors:  Athina Savva; Thierry Roger
Journal:  Front Immunol       Date:  2013-11-18       Impact factor: 7.561

View more
  4 in total

1.  Blood-stage malaria of Plasmodium chabaudi induces differential Tlr expression in the liver of susceptible and vaccination-protected Balb/c mice.

Authors:  Saleh Al-Quraishy; Mohamed A Dkhil; Suliman Alomar; Abdel Azeem S Abdel-Baki; Denis Delic; Frank Wunderlich; Marcos J Araúzo-Bravo
Journal:  Parasitol Res       Date:  2016-01-25       Impact factor: 2.289

2.  Liver-inherent immune system: its role in blood-stage malaria.

Authors:  Frank Wunderlich; Saleh Al-Quraishy; Mohamed A Dkhil
Journal:  Front Microbiol       Date:  2014-11-04       Impact factor: 5.640

3.  Protective Vaccination against Blood-Stage Malaria of Plasmodium chabaudi: Differential Gene Expression in the Liver of Balb/c Mice toward the End of Crisis Phase.

Authors:  Saleh A Al-Quraishy; Mohamed A Dkhil; Abdel-Azeem A Abdel-Baki; Denis Delic; Frank Wunderlich
Journal:  Front Microbiol       Date:  2016-07-14       Impact factor: 5.640

Review 4.  Epigenetics and Malaria Susceptibility/Protection: A Missing Piece of the Puzzle.

Authors:  Charles Arama; Jaclyn E Quin; Bourèma Kouriba; Ann-Kristin Östlund Farrants; Marita Troye-Blomberg; Ogobara K Doumbo
Journal:  Front Immunol       Date:  2018-08-03       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.